Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/110769
Title: Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway
Author: Chaccour, Carlos
Rabinovich, N. Regina
Keywords: Malària
Assaigs clínics
Malaria
Clinical trials
Issue Date: 24-Apr-2017
Publisher: Biomed Central
Abstract: The development of ivermectin as a complementary vector control tool will require good quality evidence. This paper reviews the different eco-epidemiological contexts in which mass drug administration with ivermectin could be useful. Potential scenarios and pharmacological strategies are compared in order to help guide trial design. The rationale for a particular timing of an ivermectin-based tool and some potentially useful outcome measures are suggested.
Note: Reproducció del document publicat a: http://dx.doi.org/10.1186/s12936-017-1802-3
It is part of: Malaria Journal, 2017, vol. 16, num. 1, p. 166
Related resource: http://dx.doi.org/10.1186/s12936-017-1802-3
URI: http://hdl.handle.net/2445/110769
ISSN: 1475-2875
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
chaccour2017_2515.pdf1.05 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons